Characterization of lymphocyte‐rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures
Liver International · 2024-05 · 44 (5) · 1202-1218
DOI: 10.1111/liv.15865 ↗Kurz gefasst
Fachartikel in der Zeitschrift Liver International, online erschienen am 16.02.2024. Verfasst von Bokyung Ahn und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Tertiary Lymphoid Structures. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Asan Institute for Life Sciences, Asan Medical Center, National Research Foundation of Korea.
Abstract (Originalsprache)
Background & Aims Lymphocyte‐rich hepatocellular carcinoma (LR‐HCC) is largely unknown and a rare subtype of HCC with immune‐rich stroma. Tertiary lymphoid structures (TLS), frequently observed in LR‐HCC, are known to be prognostically significant in various malignancies; however, their significance in HCC remains unevaluated.
Methods
Clinicopathologic data of 191 cases of surgically resected conventional HCC (C‐HCC, n = 160) and LR‐HCC ( n = 31) were retrieved. Immunohistochemistry, multiplex immunofluorescence staining, RNA sequencing and proteomic analysis were conducted. Differences between the subtypes were statistically evaluated.
Results
LR‐HCC was significantly correlated to larger tumour size, higher Edmondson–Steiner grade, presence of TLS and higher CD3‐, CD8‐ and FOXP3‐positive T cell, high PD‐1 and PD‐L1 expression ( p < .001 for all) compared to C‐HCC. Patients with LR‐HCC exhibited significantly better overall survival (OS) ( p = .044) and recurrence‐free survival (RFS) ( p = .025) than C‐HCC. LR‐HCC demonstrated TLS signatures with significantly higher proteomic‐based immune scores in 14 of 17 types of tumour‐infiltrating immune cells. Furthermore, C‐HCC with secondary follicles, the most mature form of TLS, exhibited significantly better OS ( p = .031) and RFS ( p = .033) than those without. Across the global proteome, LR‐HCC was well‐differentiated from C‐HCC and a map of protein–protein interactions between tumour‐infiltrating lymphocytes and HCC in tumour microenvironment was completed.
Conclusion
LR‐HCC is clinicopathologically and molecularly distinct and shows better prognosis compared to C‐HCC. Also, the presence of secondary follicle can be an important prognostic marker for better prognosis in both LR‐HCC and C‐HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Department of Convergence Medicine, Asan Institute for Life Sciences, Asan Medical Center, Seoul, Republic of Korea.
- Division of Hepato-Biliary and Pancreatic Surgery, Department of Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
- Department of Medicine, University of Ulsan College of Medicine, Seoul, Republic of Korea.
- Asan Institute for Life Sciences, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Republic of Korea.
- Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
ORCID-Profile: Bokyung Ahn, Hee-Sung Ahn, Jinho Shin, Eunsung Jun, Chang Ohk Sung, Ju Hyun Shim, JeongYeon Hong, Kyunggon Kim, Hyo Jeong Kang
Förderung
- Asan Institute for Life Sciences, Asan Medical Center
- National Research Foundation of Korea
Zitieren
APA
Ahn, B., Ahn, H. S., Shin, J., Jun, E., Koh, E. Y., Ryu, Y. M., Kim, S. Y., Sung, C. O., Shim, J. H., Hong, J., Kim, K., & Kang, H. J. (2024). Characterization of lymphocyte‐rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures. Liver International, 44(5), 1202-1218. https://doi.org/10.1111/liv.15865
Vancouver
Ahn B, Ahn HS, Shin J, Jun E, Koh EY, Ryu YM, et al. Characterization of lymphocyte‐rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures. Liver International. 2024;44(5):1202-1218. doi:10.1111/liv.15865
BibTeX
@article{Ahn2024,
author = {Ahn, Bokyung and Ahn, Hee-Sung and Shin, Jinho and Jun, Eunsung and Koh, Eun-Young and Ryu, Yeon-Mi and Kim, Sang-Yeob and Sung, Chang Ohk and Shim, Ju Hyun and Hong, JeongYeon and Kim, Kyunggon and Kang, Hyo Jeong},
title = {Characterization of lymphocyte‐rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures},
journal = {Liver International},
year = {2024},
volume = {44},
number = {5},
pages = {1202--1218},
doi = {10.1111/liv.15865}
}
EUVIMED